We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACIW icon
1001
ACI Worldwide
ACIW
$5.33B
$44.7M ﹤0.01%
1,420,886
+18,462
+1% +$616K
MORF
1002
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$44.7M ﹤0.01%
1,112,651
-33,710
-3% -$1.41M
TWTR
1003
DELISTED
Twitter, Inc.
TWTR
$44.4M ﹤0.01%
1,148,421
-54,916
-5% -$2.01M
GO icon
1004
Grocery Outlet
GO
$1.07B
$44.3M ﹤0.01%
1,350,621
-87,819
-6% -$2.45M
PLAN
1005
DELISTED
Anaplan, Inc.
PLAN
$44.3M ﹤0.01%
680,517
-528,169
-44% -$25.7M
CHCT
1006
Community Healthcare Trust
CHCT
$430M
$44.2M ﹤0.01%
1,046,541
+7,525
+0.7% +$326K
EQBK icon
1007
Equity Bancshares
EQBK
$1.06B
$43.9M ﹤0.01%
1,358,780
-6,823
-0.5% -$222K
LITE icon
1008
Lumentum
LITE
$78B
$43.8M ﹤0.01%
448,409
+153,148
+52% +$15M
CBRE icon
1009
CBRE Group
CBRE
$42.7B
$43.7M ﹤0.01%
477,660
-26,450
-5% -$2.58M
HR
1010
DELISTED
Healthcare Realty Trust Incorporated
HR
$43.7M ﹤0.01%
1,590,453
-3,301,165
-67% -$97.3M
CNK icon
1011
Cinemark Holdings
CNK
$4.32B
$43.3M ﹤0.01%
2,507,104
-55,781
-2% -$927K
PRVA icon
1012
Privia Health
PRVA
$2.75B
$43.2M ﹤0.01%
1,617,934
+499,816
+45% +$11.8M
CPAAU
1013
DELISTED
Conyers Park III Acquisition Corp. Unit
CPAAU
$43.2M ﹤0.01%
4,303,291
DENN
1014
DELISTED
Denny's
DENN
$43.2M ﹤0.01%
3,018,813
+40,966
+1% +$624K
RENT
1015
Rent the Runway
RENT
$119M
$43.2M ﹤0.01%
318,697
+1,685
+0.5% +$198K
MUSA icon
1016
Murphy USA
MUSA
$10.1B
$43.2M ﹤0.01%
215,796
+11,554
+6% +$2.17M
IIIV icon
1017
i3 Verticals
IIIV
$323M
$43.1M ﹤0.01%
1,545,463
-9,187
-0.6% -$227K
BSKYU
1018
DELISTED
Big Sky Growth Partners, Inc. Unit
BSKYU
$43M ﹤0.01%
4,388,156
CDK
1019
DELISTED
CDK Global, Inc.
CDK
$43M ﹤0.01%
884,078
+811,625
+1,120% +$36.3M
BOX icon
1020
Box
BOX
$4.48B
$43M ﹤0.01%
1,480,473
+9,847
+0.7% +$259K
REX icon
1021
REX American Resources
REX
$1.44B
$42.9M ﹤0.01%
2,585,142
-843,690
-25% -$13.6M
BEN icon
1022
Franklin Resources
BEN
$17.1B
$42.8M ﹤0.01%
1,534,093
-255,435
-14% -$7.8M
CZR icon
1023
Caesars Entertainment
CZR
$6.04B
$42.7M ﹤0.01%
552,258
-16,191
-3% -$1.3M
CWAN
1024
DELISTED
Clearwater Analytics
CWAN
$42.2M ﹤0.01%
2,009,751
-2,493
-0.1% -$46.6K
CVLT icon
1025
Commault Systems
CVLT
$6.26B
$42.2M ﹤0.01%
635,354
+510
+0.1% +$33.5K

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.